Public Law 119-37, Section 781 — what actually changes on November 12, 2026, which SKUs survive, and how Steve's Goods has been building for this rule since 2016.
Not legal advice. Current as of April 14, 2026. H.R. 5371 implementing guidance is still being issued. Product positioning language on this page is a compliance posture summary, not a batch-level certification. Confirm current federal and state rules with qualified counsel before shipping or stocking decisions.
This page is the single source we keep current for operators building a multi-state CBD gummy program into and through the November 12, 2026 federal transition. If you are deciding whether a SKU survives H.R. 5371, whether a white-label run is worth starting in April, or whether a state-level lane still makes sense — start here, then drop into the state-by-state guide for the markets that matter to you. If you want the cleanest operational summary in one sentence: the federal hemp lane is getting narrower, and it is getting narrower in a specific, measurable way.
Public Law 119-37, Section 781 — the provision people usually call H.R. 5371 — rewrites how the federal government measures whether a finished hemp product is still hemp. The old rule, set by the 2018 Farm Bill, measured only delta-9 THC against the 0.3% dry-weight standard. The new rule keeps that threshold but, once implementing guidance is finalized, is expected to apply it to a total-THC figure that counts the delta-9-THC equivalent produced when THCA in the product decarboxylates. Depending on how that guidance is written, a SKU that cleared the old delta-9-only test may not clear the new test without any change in formulation — but the exact crossover point cannot be stated until the final agency protocol is published.
The enforcement date is November 12, 2026. After that date, products manufactured, shipped, or sold in federal commerce need to meet the new math. Inventory produced before the date is not grandfathered by the statute. Operators should treat November 12 as a formulation and catalog deadline, not just a legal one.
Under the old delta-9-only framework, a product could carry a high THCA load and still test as federally compliant hemp, because THCA is a non-intoxicating precursor in its acid form. Industry reporting and regulatory commentary have widely described a gap between "what the delta-9-only test reads" and the intoxicating products that some operators built around THCA — the federal shift to a total-THC framework is the policy response to that gap. The precise scientific assumptions in the new framework, including which conversion ratio regulators will apply, are part of the rulemaking still being finalized. Operators should not treat any single conversion number as settled until the final guidance is issued.
The new federal standard closes that gap at the measurement layer. Regulators now look at the total of delta-9 THC present in the product plus the delta-9-THC equivalent that would be produced if the THCA were fully decarboxylated, and that combined number has to stay under 0.3% of dry weight. The exact lab protocol is still being finalized at the agency level, but the operational implication is already clear: THCA-heavy products designed to slip under a delta-9-only test are the primary category affected.
The federal statute works in percentage terms, but most practical enforcement happens at the finished-product level. That is where state regulators have been faster to set bright lines than the federal agencies. Ohio, as one of the cleanest examples, already excludes any finished hemp-derived cannabinoid product above roughly 0.4 mg of combined total-THC-like cannabinoids per container from its hemp definition. Several other states are moving toward similar per-container or per-serving caps.
For operators running a multi-state catalog, the per-container figure — not the percentage — is usually the real design constraint. A product that runs 0.25% total-THC by weight can still blow past a state's 0.4 mg-per-container line if the package is large enough. The cleaner approach for 2026 is to design finished SKUs around the tightest reasonable per-container total-THC figure and then validate that the percentage math also clears the federal floor, rather than the other way around.
Not every product category is equally affected by H.R. 5371. The realistic split looks like this.
CBD isolate gummies. Low-THC broad-spectrum ingestibles. CBG and CBN minor-cannabinoid formulations. Topicals and tinctures with minimal THC contribution. Most conservative full-spectrum SKUs built around the 2018 Farm Bill and already running under per-serving discipline. Final status still depends on the published federal protocol and the state-level rules in each shipping lane.
Full-spectrum ingestibles on the looser end of the 0.3% delta-9 spectrum. Edibles with high total mg per container. Products whose packaging or messaging leans on an intoxicating cue. Most of this category becomes compliant with a formulation tweak, a smaller container size, or a language change — not a full exit.
Delta-8 THC products. Delta-9 products that rely on THCA-for-delta-9 conversion math. Synthetically converted cannabinoids sold as hemp. High-per-serving edibles designed for an intoxicating dose. Hemp flower positioned for inhalation effect. These are the categories the new framework is specifically written to address.
Even inside the "likely survives" column, some states have category-level bans that override federal status. Inhalables in California, shipping restrictions in Idaho, finished-form rules in New York. Federal compliance is the floor — state compliance is the daily operational reality.
Steve's Goods has operated its 3,700 sq ft Louisville manufacturing facility since 2016 with a conservative cannabinoid profile: low total-THC, high CBD and minor-cannabinoid formulations, real-food ingredients, and per-container math designed around the strictest finished-product rules we already had to ship into. That posture aligns with the direction of the new federal framework. Wholesale partners who built on our gummies in 2023 and 2024 generally do not face the same reformulation exposure as operators whose catalogs were built around delta-8 or high-THCA SKUs.
For retailers and distributors, that matters in two practical ways. First, our stock CBD, full-spectrum, CBG, and CBN gummies are built on a low-THC profile consistent with the direction of H.R. 5371, though final compliance for any finished product cannot be certified until federal implementing guidance is issued and a batch-specific COA is tested against it. Second, our private-label and white-label programs can onboard a brand that needs to pivot out of delta-8 or high-THCA SKUs in about the same timeline we onboard any new partner — we do not have a legacy catalog of intoxicating SKUs we are trying to save.
For operators who need to move product off the "reformulate-or-exit" line of the matrix above, the usual path has three steps. One, confirm the finished-product total-THC math against both the new federal floor and every state lane you currently ship into — there is no reason to reformulate to the federal line if your most important state is tighter. Two, decide whether the product stays in the same category at a lower potency, moves to a different cannabinoid profile (CBD, CBG, CBN, low-dose full spectrum), or exits the catalog entirely. Three, run a small compliance batch, validate the COA against both percentage and per-container tests, and only then build a full production order.
The statutory enforcement date is November 12, 2026 — roughly seven months from today as of April 2026. Based on typical lead times we see on our own wholesale program (packaging redesign, label approvals, batch testing, and retail re-set), operators who are starting a reformulation in April with intoxicating SKUs still in catalog should plan for the possibility of a short inventory gap if the federal implementing guidance lands late in the window. We share this as operational experience, not as a regulatory forecast.
Federal law sets the floor. State law sets the shipping map. Every one of the 50 states has its own posture — some are already tighter than H.R. 5371, some are looser but drifting, and some have category-level bans that override the federal rule entirely. Use these state guides to check the lane before you ship.
If you prefer a single comparison hub rather than reading state by state, the CBD gummy compliance guide by state collects the main THC, testing, and age rules into one page. For the underlying structured regulatory data we use to build these summaries, see HempData.
H.R. 5371 is the short name for the federal hemp provisions enacted as Public Law 119-37, Section 781. It rewrites how the federal government measures hemp compliance by moving from a delta-9-only threshold to a total-THC framework that counts THCA after decarboxylation against the 0.3% dry-weight standard. Enforcement is set for November 12, 2026.
No. Hemp-derived CBD products that do not rely on THCA-for-delta-9 conversion stay within the federal hemp lane. The law targets intoxicating hemp products — delta-8, delta-9 from THCA flower, synthetically converted cannabinoids, and high-per-serving edibles — not ordinary CBD wellness products.
Instead of measuring only delta-9 THC in a finished product, regulators under the new framework also count the delta-9 THC that would be produced if the THCA in the product were heated (decarboxylated). That combined number must stay under the 0.3% dry-weight threshold for the product to remain federally compliant hemp.
Several states — Ohio is the clearest example — already exclude any finished hemp product above roughly 0.4 mg of combined total-THC-like cannabinoids per container from their definition of legal hemp. This is a state-level bright line, not the exact federal formula, but it signals where many regulators are heading. Operators building a multi-state catalog are increasingly using it as a practical design target.
That is the enforcement date in Public Law 119-37. Products manufactured, shipped, or sold in federal commerce after that date must meet the new total-THC framework. Inventory that was legal to produce before the date but does not meet the new math is expected to be a reformulate-or-exit decision for the operator, not a grandfathered SKU.
As of April 2026, our bulk CBD, full-spectrum, CBG, and CBN gummies are built around low-THC, non-intoxicating cannabinoid profiles — the same profile we have produced since 2016. Final federal lab-protocol guidance for H.R. 5371 has not yet been issued, and definitive "compliant" status for any hemp product cannot be certified until that guidance is published and a finished-product COA is tested against it. Retailers evaluating for the November 12, 2026 transition should request current COAs and a signed compliance statement from any manufacturer before stocking — ours included.
It depends on the product. Low-THC CBD tinctures, isolate-based gummies, topicals, and most conservative full-spectrum ingestibles are usually workable with labeling and COA changes only. Delta-8, delta-9 from THCA, high-per-serving edibles, and intoxicating hemp flower almost always need a real reformulation or a category exit. We walk operators through this in a quote call.
Federal law sets a floor. States can still be stricter, and as of April 2026 many already are — see our 50 state compliance guides for the current posture in each. State rules change frequently; any shipping decision should re-check the state-level rule at the time of shipment, not rely on a prior characterization. The practical implication is that a product can clear the new federal total-THC rule and still be unlawful to ship into a state that bans the product type or caps per-container THC more tightly.
We use the HempData regulatory database as our primary structured source, then cross-check each state’s agency page and recent rulemaking before we certify a shipping lane. That is the same data surface we expose to wholesale customers who want state-by-state clarity on where their formula can sell.
No. This is a compliance summary written to help retailers, distributors, and brand owners make informed operational decisions. High-volume shipping, THC-forward products, or category transitions still deserve a current attorney review before you rely on any single source operationally.
Not legal advice. Information current as of April 14, 2026. H.R. 5371 implementing guidance has not yet been fully issued as of this date. Nothing on this page — including statements about Steve's Goods product positioning, the product survival matrix, or any state-by-state characterization — is a certification of current or future legal compliance for your specific operation. Regulatory posture can change between this page's publication and your next shipment. Retailers, distributors, and brand owners should confirm current federal and state rules with qualified counsel and request a current COA and manufacturer compliance statement on each batch before making stocking or shipping decisions.
Tell us what you're currently selling and where you need to ship. We'll walk you through the compliant private-label and white-label options in a 20-minute quote call.
Request a Quote →